Rheumatoid Arthritis Clinical Trials in New York

Showing 321-340 of 3,596 trials

Conduction System Pacing International Registry (CONSPIRE)

NCT04831125

The purpose of this registry study is to collect information about routine clinical practices with device implantation to treat bradycardia and cardiac systolic dysfunction (heart rhythm disorders) across global centers of excellence in cardiac pacing. In particular, this study will examine the use of conduction system pacing (CSP) in clinical practice. Information collected in the registry will help researchers better characterize strengths and limitations of current technology and treatments.

BradyarrhythmiaHeart Failure

University of Chicago383 participantsStarted Apr 2021

Tucson, Arizona, United States • Chicago, Illinois, United States • New York, New York, United States +5 more locations

RECRUITINGPhase 3< 1 mile

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis

NCT05784246

The main purpose of this study is to investigate efficacy, pharmacokinetics and safety of the drug in pediatric participants with moderately to severely active ulcerative colitis (UC).

Ulcerative Colitis

Eli Lilly and Company60 participantsStarted Nov 2023

San Francisco, California, United States • Atlanta, Georgia, United States • Indianapolis, Indiana, United States +31 more locations

Conduction System Pacing International Registry (CONSPIRE)

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis

Rheumatoid Arthritis Trials in Other Cities

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment

Nutritional Supplementation in Geriatric Hip Fractures

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis

"Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nulcectomy" (LOPAIN2)

Other Conditions in New York